• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc ALNY

Last Price$75.88Day Change (%)0.41%
Open Price$77.25Day Change ($)0.31
Day Range75.25–77.2552-Week Range49.96–110.75

As of Mon 9/26/2016 2:16:00 PM | USD

  1. All
  2. 3rd Party
  1. Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1

    Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1

  2. Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight - Research and Markets

    Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight - Research and Markets

  3. Dodge & Cox Balanced Fund Isn't for Everyone

    This Gold-rated fund is not a safe choice, but it's a strong one for the right kind of investor.

  4. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.